E2F6-Mediated Downregulation of MIR22HG Facilitates the Progression of Laryngocarcinoma by Targeting the miR-5000-3p/FBXW7 Axis

REFERENCES

• McGuire S. 2016. World cancer report 2014—Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7:418–419.
   PubMed Web of Science ®Google Scholar
• Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A, Siegel RL. 2018. Cancer statistics for Hispanics/Latinos, 2018. CA Cancer J Clin 68:425–445. https://doi.org/10.3322/caac.21494.
   PubMed Web of Science ®Google Scholar
• Lampri ES, Chondrogiannis G, Ioachim E, Varouktsi A, Mitselou A, Galani A, Briassoulis E, Kanavaros P, Galani V. 2015. Biomarkers of head and neck cancer, tools or a gordian knot? Int J Clin Exp Med 8:10340–10357.
   PubMed Web of Science ®Google Scholar
• Li P, Liu H, Wang Z, He F, Wang H, Shi Z, Yang A, Ye J. 2016. MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy. Am J Transl Res 8:1935–1944.
   PubMed Web of Science ®Google Scholar
• Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. 2006. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13. https://doi.org/10.1097/01.mlg.0000236095.97947.26.
   PubMed Web of Science ®Google Scholar
• Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. 2006. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 32:504–515. https://doi.org/10.1016/j.ctrv.2006.07.002.
   PubMed Web of Science ®Google Scholar
• Larbcharoensub N, Cheewaruangroj W, Nitiyanant P. 2011. Laryngeal sarcocystosis accompanying laryngeal squamous cell carcinoma: case report and literature review. Southeast Asian J Trop Med Public Health 42:1072–1076.
   PubMed Web of Science ®Google Scholar
• Gama RR, Carvalho AL, Longatto Filho A, Scorsato AP, López RVM, Rautava J, Syrjänen S, Syrjänen K. 2016. Detection of human papillomavirus in laryngeal squamous cell carcinoma: systematic review and meta-analysis. Laryngoscope 126:885–893. https://doi.org/10.1002/lary.25738.
   PubMed Web of Science ®Google Scholar
• Markou K, Christoforidou A, Karasmanis I, Tsiropoulos G, Triaridis S, Constantinidis I, Vital V, Nikolaou A. 2013. Laryngeal cancer: epidemiological data from northern Greece and review of the literature. Hippokratia 17:313–318.
   PubMed Web of Science ®Google Scholar
• He FY, Liu HJ, Guo Q, Sheng JL. 2017. Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci 21:760–764.
   PubMed Web of Science ®Google Scholar
• Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. 2013. Analysis of long noncoding RNA expression profiles in gastric cancer. World J Gastroenterol 19:3658–3664. https://doi.org/10.3748/wjg.v19.i23.3658.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. 2009. MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47:5–14. https://doi.org/10.1016/j.yjmcc.2009.01.008.
   PubMed Web of Science ®Google Scholar
• Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, Arcaro KF. 2013. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. J Cell Biochem 114:1385–1394. https://doi.org/10.1002/jcb.24480.
   PubMed Web of Science ®Google Scholar
• Guo W, Ren D, Chen X, Tu X, Huang S, Wang M, Song L, Zou X, Peng X. 2013. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. J Cell Biochem 114:1606–1615. https://doi.org/10.1002/jcb.24502.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. 2009. Evolution and functions of long noncoding RNAs. Cell 136:629–641. https://doi.org/10.1016/j.cell.2009.02.006.
   PubMed Web of Science ®Google Scholar
• Xiang J, Guo S, Jiang S, Xu Y, Li J, Li L, Xiang J. 2016. Silencing of long non-coding RNA MALAT1 promotes apoptosis of glioma cells. J Korean Med Sci 31:688–694. https://doi.org/10.3346/jkms.2016.31.5.688.
   PubMed Web of Science ®Google Scholar
• Evans JR, Feng FY, Chinnaiyan AM. 2016. The bright side of dark matter: lncRNAs in cancer. J Clin Invest 126:2775–2782. https://doi.org/10.1172/JCI84421.
   PubMed Web of Science ®Google Scholar
• Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ, Lam WL. 2011. Human cancer long noncoding RNA transcriptomes. PLoS One 6:e25915. https://doi.org/10.1371/journal.pone.0025915.
   PubMed Web of Science ®Google Scholar
• Moran VA, Perera RJ, Khalil AM. 2012. Emerging functional and mechanistic paradigms of mammalian long noncoding RNAs. Nucleic Acids Res 40:6391–6400. https://doi.org/10.1093/nar/gks296.
   PubMed Web of Science ®Google Scholar
• Long B, Li N, Xu XX, Li XX, Xu XJ, Liu JY, Wu ZH. 2018. Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1. Biochem Biophys Res Commun 505:561–568. https://doi.org/10.1016/j.bbrc.2018.09.160.
   PubMed Web of Science ®Google Scholar
• Wang YG, Wang T, Shi M, Zhai B. 2019. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. J Exp Clin Cancer Res 38:153. https://doi.org/10.1186/s13046-019-1128-9.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y. 2019. Long noncoding RNA (lncRNA) MIR22HG suppresses gastric cancer progression through attenuating NOTCH2 signaling. Med Sci Monit 25:656–665. https://doi.org/10.12659/MSM.912813.
   PubMed Web of Science ®Google Scholar
• Cui Z, An X, Li J, Liu Q, Liu W. 2018. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation. Biomed Pharmacother 104:223–228. https://doi.org/10.1016/j.biopha.2018.05.046.
   PubMed Web of Science ®Google Scholar
• Liu T, Wang W, Xu YC, Li ZW, Zhou J. 2019. Long noncoding RNA NEAT1 functions as an oncogene in human laryngocarcinoma by targeting miR-29a-3p. Eur Rev Med Pharmacol Sci 23:6234–6241. https://doi.org/10.26355/eurrev_201907_18442.
   PubMed Web of Science ®Google Scholar
• Zhuang S, Liu F, Wu P. 2019. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis. J Cell Biochem 120:13392–13402. https://doi.org/10.1002/jcb.28614.
   PubMed Web of Science ®Google Scholar
• Xu S, Guo J, Zhang W. 2019. lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis. J Cell Biochem 120:12810–12821. https://doi.org/10.1002/jcb.28552.
   PubMed Web of Science ®Google Scholar
• Jiang C, Yang Y, Yang Y, Guo L, Huang J, Liu X, Wu C, Zou J. 2018. Long noncoding RNA (lncRNA) HOTAIR affects tumorigenesis and metastasis of non-small cell lung cancer by upregulating miR-613. Oncol Res 26:725–734. https://doi.org/10.3727/096504017X15119467381615.
   PubMed Web of Science ®Google Scholar
• Xia ZS, Wang L, Yu T, Zhong W, Lian GD, Wu D, Zhou HM, Chen GC. 2014. miR-5000-3p, miR-5009-3P and miR-552: potential microRNA biomarkers of side population cells in colon cancer. Oncol Rep 32:589–596. https://doi.org/10.3892/or.2014.3232.
   PubMed Web of Science ®Google Scholar
• Ghini F, Rubolino C, Climent M, Simeone I, Marzi MJ, Nicassio F. 2018. Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation. Nat Commun 9:3119. https://doi.org/10.1038/s41467-018-05182-9.
   PubMed Web of Science ®Google Scholar
• Xiao G, Li Y, Wang M, Li X, Qin S, Sun X, Liang R, Zhang B, Du N, Xu C, Ren H, Liu D. 2018. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation. Cell Prolif 51:e12473. https://doi.org/10.1111/cpr.12473.
   Google Scholar
• Mori A, Masuda K, Ohtsuka H, Shijo M, Ariake K, Fukase K, Sakata N, Mizuma M, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Fujishima F, Unno M. 2018. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1. Cancer Sci 109:3883–3895. https://doi.org/10.1111/cas.13829.
   PubMed Web of Science ®Google Scholar
• Cheng FHC, Lin HY, Hwang TW, Chen YC, Huang RL, Chang CB, Yang W, Lin RI, Lin CW, Chen GCW, Mai SY, Lin JMJ, Chuang YM, Chou JL, Kuo LW, Li C, Cheng ASL, Lai HC, Wu SF, Tsai JC, Chan M. 2019. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness. Cancer Sci 110:1085–1095. https://doi.org/10.1111/cas.13920.
   PubMed Web of Science ®Google Scholar
• Yuan S, Xiang Y, Wang G, Zhou M, Meng G, Liu Q, Hu Z, Li C, Xie W, Wu N, Wu L, Cai T, Ma X, Zhang Y, Yu Z, Bai L, Li Y. 2019. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer. Mol Oncol 13:840–856. https://doi.org/10.1002/1878-0261.12437.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang L, Lv S, Xu H, Fan Z, He Y, Wen H. 2019. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma. Life Sci 232:116649. https://doi.org/10.1016/j.lfs.2019.116649.
   PubMed Web of Science ®Google Scholar